POLICY  •  NEWS  •  MARKETS

AG POLICY & MARKETS DAILY

THURSDAY, JULY 30, 2026   |   SPECIAL REPORT & ANALYSIS

EARNINGS ANALYSIS  |  CORTEVA Q2 2026

Corteva Raises 2026 Outlook as Margin Gains Offset Sales Miss

Profit beat masks softer volumes ahead of the October seed separation
 

Analysis  ·  July 30, 2026

Corteva delivered better-than-expected second-quarter earnings and raised its full-year profit forecast, but investors focused on declining sales, weak crop-protection volumes and continued pricing pressure in Latin America. The company released results Thursday, July 30, after the market closed and will hold its earnings call Friday at 9 a.m. ET.

The Indianapolis-based agricultural technology company reported operating earnings of $2.30 per share, up 5% from a year earlier and above the roughly $2.22 to $2.23 analysts had expected. Operating EBITDA increased 4% to $2.26 billion, even though net sales declined 1% to $6.38 billion. Revenue missed the $6.58 billion LSEG consensus, sending Corteva shares down about 3.7% in after-hours trading.

The central message is that Corteva is generating more profit from less revenue. Operating EBITDA margin improved by more than 190 basis points as higher seed pricing, royalty savings, productivity initiatives and cost controls offset lower volumes. That is an encouraging sign for earnings durability, but the revenue miss raises questions about how much longer operating efficiencies can compensate for subdued agricultural demand.

The Quarter at a Glance

GAAP results were weaker than the operating numbers. Income from continuing operations fell 12% to $1.22 billion, while GAAP earnings declined 10% to $1.81 per share. The gap between GAAP and operating results partly reflected $79 million of separation costs, higher intangible-asset amortization and a negative swing in other income and expense.

Table 1. Corteva’s second-quarter 2026 scorecard: a profit beat on a revenue miss. Sources: Company reports; LSEG consensus estimates.

The pattern across the income statement is consistent: every measure of profitability improved on an operating basis while every measure of demand softened. First-half results tell the same story in stronger form, with operating EBITDA up 10% to $3.70 billion and operating earnings up 14% to $3.80 per share.

Figure 1. Profit up, sales down: year-over-year change in key Q2 and first-half measures. Sources: Company reports.

Seed Business Shows Pricing Power

Corteva’s Seed division remained the principal earnings engine. Second-quarter Seed sales were essentially unchanged at $4.53 billion, as a 3% increase in price and product mix offset a 3% volume decline. Seed operating EBITDA increased 6% to $1.97 billion, and the segment’s operating margin expanded by more than 230 basis points.

The results indicate that farmers remain willing to pay for genetics and traits that provide a clear yield or risk-management benefit, even as lower crop margins make them more selective elsewhere. Corteva cited demand for its newest technology, increased licensing income and lower royalty expense as important profit drivers.

The crop mix also mattered. Lower corn acreage in North America was offset partly by increased soybean acreage, while European acreage shifted from corn toward sunflowers. Corteva’s detailed product data showed second-quarter corn-seed sales declining 3%, while soybean-seed sales increased 5% and other oilseed sales climbed 23%.

Figure 2. The acreage shift shows up in Corteva’s seed lineup: corn down, soybeans and other oilseeds up. Sources: Company reports.

That shift is favorable for Corteva’s soybean traits and licensing business, but it is not entirely positive for the combined company. Corn generally carries more seed revenue per acre and supports heavier spending on fertilizer and certain crop-protection products. A sustained shift toward soybeans therefore changes where Corteva earns its money rather than producing an unqualified increase in demand.

Crop Protection Remains the Vulnerable Side

Crop Protection sales declined 4% to $1.85 billion, with organic sales falling 6%. Prices decreased 4%, volumes declined 2% and favorable currency movements added 2%. North American sales fell 12%, largely because of channel-purchasing timing, while dry conditions weighed on European demand and competitive pricing continued to pressure Latin America.

Despite the sales decline, Crop Protection operating EBITDA increased 2% to $342 million, with margins improving by more than 110 basis points. Cost reductions, productivity improvements and currency benefits more than offset the effects of lower prices and volumes.

Figure 3. What moved Q2 sales in each segment: seed pricing was the only meaningful positive driver; crop-protection prices and volumes both fell. Sources: Company reports.

The margin performance is impressive, but the composition is less reassuring than the headline earnings number. Crop Protection is still confronting price deflation in Latin America, uneven distributor ordering in North America and cautious farmer spending. Those pressures could become more visible during the seasonally smaller second half, when there is less seed income available to absorb weakness elsewhere.

Inside the Numbers

Strip the quarter down to its components and the pattern is unmistakable: essentially all of Corteva’s profit growth came from margin, not from demand. Seed pricing was the only meaningful positive revenue driver in the entire company, and it was worth just 3 points on a little over two-thirds of sales. Everything else — crop-protection prices, volumes in both segments — subtracted from the top line.

Table 2. Segment results: Seed generated roughly 85% of segment operating EBITDA in the quarter. Sources: Company reports.

The segment table also quantifies how lopsided the earnings mix has become in the seasonally seed-heavy first half. Seed produced roughly 85% of segment operating EBITDA in the quarter, which means each point of seed pricing is worth far more to consolidated results than a point of crop-protection cost savings. That concentration flatters results now, but it also explains why the second half — when the seed contribution shrinks and Latin American crop protection dominates the calendar — carries most of the remaining risk to the year.

Guidance Increase Confirms Confidence

Corteva raised its 2026 operating EBITDA forecast to $4.1 billion to $4.3 billion, compared with its previous range of $4.0 billion to $4.2 billion. Operating earnings guidance increased to $3.60 to $3.80 per share, up from $3.45 to $3.70. The midpoint of the new EBITDA range is slightly above the $4.18 billion analyst consensus reported by LSEG.

Table 3. Corteva’s raised 2026 guidance. Sources: Company guidance; LSEG consensus estimates.

Management attributed the increase to the strong first half, additional productivity benefits and continued adoption of differentiated seed and crop-protection products. First-half operating EBITDA rose 10% to $3.70 billion, while operating earnings increased 14% to $3.80 per share.

The Second-Half Math

The raised outlook nevertheless implies a comparatively modest contribution from the second half, and the arithmetic is worth spelling out. With $3.70 billion of operating EBITDA already delivered in the first half, the new $4.1 billion to $4.3 billion full-year range implies second-half operating EBITDA of just $400 million to $600 million — normal for an agricultural calendar in which the first half carries the big Northern Hemisphere seed season, but a reminder of how little cushion the back half provides.

Figure 4. The guidance arithmetic: $3.70 billion of first-half operating EBITDA leaves an implied second-half contribution of only $0.4 billion to $0.6 billion. Sources: Company reports and guidance; Ag Policy & Markets Daily calculations.

The per-share math is even more striking. Corteva has already earned $3.80 of operating earnings per share in the first half — at or above the top of the new $3.60 to $3.80 full-year range. Guidance therefore implies second-half operating results between roughly breakeven and a 20-cent loss per share. That is seasonally normal for this business, but it underscores that the full-year raise is effectively a first-half raise: management banked the beat rather than projecting stronger second-half fundamentals. The back half also absorbs the $25 million separation-timing headwind embedded in guidance, and it is the period most exposed to Latin American crop-protection pricing — the area of the portfolio under the most pressure.

Separation Moves Into the Final Stretch

Corteva reaffirmed that it expects to spin off its Seed and genetics company, Vylor, on Oct. 1. Investor presentations for Vylor and the remaining Crop Protection-focused Corteva are scheduled for Sept. 15. The company said most ongoing dis-synergies have been offset, although the guidance includes a $25 million headwind associated with the timing of separation activities.

Figure 5. Key dates on the road to the Oct. 1 separation. Sources: Company investor communications.

The quarterly results strengthen the rationale for the separation. Vylor will begin life with strong pricing power, expanding margins and a relatively predictable stream of trait and licensing income. The remaining Corteva will have differentiated products and improving cost efficiency, but it will also inherit the more cyclical business, including exposure to generic competition, distributor inventories and Latin American price pressure.

Table 4. What each company inherits on Oct. 1. Segment results are a close, though not exact, proxy for the two post-separation companies. Sources: Company reports; Ag Policy & Markets Daily analysis.

What to Listen for on Friday’s Call

Friday’s 9 a.m. ET earnings call will be the first opportunity to pressure-test the guidance increase. Five questions matter most.

Latin American pricing. Management commentary on whether crop-protection price deflation in Brazil and Argentina is decelerating will be the single most important signal for the second half, which leans heavily on the Southern Hemisphere season.

North American channel behavior. The 12% decline in North American crop-protection sales was attributed largely to purchase timing. Listen for whether distributors are expected to restock in the third quarter or whether the channel is structurally carrying less inventory.

The second-half bridge. Analysts will press for the components of the implied $400 million to $600 million second-half EBITDA — how much cushion is built in for weather, currency and the $25 million separation-timing headwind.

Separation details ahead of Sept. 15. Any preview of capital structure, dividend policy and cost allocation for Vylor and the remaining Corteva would help investors set expectations before the formal investor presentations.

Early 2027 seed positioning. Comments on the early order book, seed pricing intentions and whether the acreage mix keeps tilting from corn toward soybeans will shape how durable Vylor’s pricing power looks heading into its first year as a stand-alone company.

Bottom line

Corteva’s earnings were better than its sales performance. The company demonstrated that premium genetics, licensing income and disciplined cost management can protect profits during a difficult farm economy. But the after-hours decline shows investors want more than margin expansion: they want evidence that underlying volumes and crop-protection pricing are stabilizing. Friday’s earnings call will be important for assessing whether the guidance increase reflects sustainable operating momentum or primarily a strong first half combined with aggressive cost execution.

Sources: Corteva second-quarter 2026 earnings release and financial schedules, July 30, 2026; LSEG consensus estimates; company guidance and investor communications. After-hours share reaction as of Thursday evening.

AG POLICY & MARKETS DAILY   |   EARNINGS ANALYSIS  |  CORTEVA Q2 2026 — THURSDAY, JULY 30, 2026